title: Early postoperative recurrence of severe Crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab.
authors: Emanuele
authors: E
authors: Sinagra
authors: Sara
authors: S
authors: Renna
authors: Filippo
authors: F
authors: Mocciaro
authors: Mirko
authors: M
authors: Olivo
authors: Mario
authors: M
authors: Cottone
authors: Ambrogio
authors: A
authors: Orlando
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy / Q000821:virology*; D003587:Cytomegalovirus / Q000187:drug effects; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D005260:Female; D015774:Ganciclovir / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy / Q000821:virology; D012008:Recurrence; D000077562:Valganciclovir
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000068879:Adalimumab; D000077562:Valganciclovir; D015774:Ganciclovir